Ecovyst Inc.(ECVT)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,708 of 2,961 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
Unusual Activity in ECVT
Events flagged as statistical outliers against ECVT's own multi-year baseline — not fixed dollar thresholds.
- Score shock2026-08-06
ECVT quality score jumped 12 points (37→48) on a new filing
View source filing →
ECVT Stock Analysis & AI Quality Score
Data updated 2026-09-11AI stock analysis and institutional research for Ecovyst Inc. (ECVT), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ECVT at 48.7/100 on a 32-signal composite quality model, placing it at rank #1,708 of 2,961 stocks — the bottom half of the AI-ranked universe. ECVT scores in the top quartile across earnings quality (86.2). Areas of concern include institutional flow (13.3) and profitability (23.2), which score below median versus the broader universe. Shareholder dilution risk is elevated at 48.9/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Ecovyst Inc. reports quarterly revenue of $250.0M, net income of $7.9M, an operating margin of 7.8%. Top institutional holders of ECVT by reported 13-F value include BlackRock, Rubric Capital Management, DIMENSIONAL FUND ADVISORS, based on the most recent SEC filings. ECVT trades on the NYSE exchange and files with the SEC under CIK 1708035. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ECVT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Ecovyst Inc. directly from SEC EDGAR. Ecovyst Inc.'s 13F Pro composite quality score has ranged between 26 and 58 since 2021, currently 48.7 — an improving long-term trajectory across 65 quarterly and live scoring snapshots.
Revenue
Q2 2026
$250.0M
Net Income
Q2 2026
$7.9M
Free Cash Flow
Q2 2026
$3.7M
Operating Margin
Q2 2026
7.8%
ROIC
Q2 2026
7.2%
D/E Ratio
Q2 2026
0.84
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+20.9% YoYNet Income
-969.2% YoYOperating Income
-23.8% YoYEPS (Diluted)
-916.7% YoYTotal Assets
-30.0% YoYTotal Debt
-54.9% YoYOp. Cash Flow
-6.4% YoYFree Cash Flow
-25.9% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $723.5M +20.9% | $598.3M +2.3% | $584.8M -28.7% | $820.2M +34.2% | $611.2M +23.2% | $495.9M |
| Net Income | $-71.1M -969.2% | $-6.7M -109.3% | $71.2M -3.5% | $73.7M +152.7% | $-139.9M +49.8% | $-278.8M |
| Operating Income | $64.9M -23.8% | $85.1M -4.9% | $89.6M -14.2% | $104.4M +91.2% | $54.6M +5.9% | $51.6M |
| EPS (Diluted) | $-0.61 -916.7% | $-0.06 -110.0% | $0.60 +9.1% | $0.55 +153.9% | $-1.02 +50.0% | $-2.04 |
| Total Assets | $1.26B -30.0% | $1.80B -1.9% | $1.84B -2.5% | $1.88B -2.4% | $1.93B -39.6% | $3.20B |
| Total Debt | $392.6M -54.9% | $869.6M -0.8% | $876.9M -0.8% | $883.9M -0.8% | $890.8M -36.4% | $1.40B |
| Operating Cash Flow | $140.3M -6.4% | $149.9M +8.9% | $137.6M -26.3% | $186.6M +43.6% | $129.9M -41.9% | $223.6M |
| Free Cash Flow | $69.9M -25.9% | $94.3M +20.0% | $78.6M -38.5% | $127.7M +82.8% | $69.9M -58.6% | $168.8M |
Get alerted when ECVT's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Ecovyst Inc. including:
Top Institutional Holders of ECVT
BlackRock, Inc.
$132.8M10,666,032 shRubric Capital Management LP
$102.2M8,211,888 shDIMENSIONAL FUND ADVISORS LP
$82.0M6,585,047 shVANGUARD PORTFOLIO MANAGEMENT LLC
$75.8M6,090,922 shFMR LLC
$66.4M5,333,701 shARROWSTREET CAPITAL, LIMITED PARTNERSHIP
$63.9M5,132,947 shVANGUARD CAPITAL MANAGEMENT LLC
$60.3M4,843,861 shBROWN ADVISORY INC
$56.4M4,533,515 shAMERICAN CENTURY COMPANIES INC
$43.3M3,474,853 shGEODE CAPITAL MANAGEMENT, LLC
$39.2M3,149,827 sh
| Fund | Value | Shares |
|---|---|---|
| BlackRock, Inc. | $132.8M | 10,666,032 |
| Rubric Capital Management LP | $102.2M | 8,211,888 |
| DIMENSIONAL FUND ADVISORS LP | $82.0M | 6,585,047 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $75.8M | 6,090,922 |
| FMR LLC | $66.4M | 5,333,701 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $63.9M | 5,132,947 |
| VANGUARD CAPITAL MANAGEMENT LLC | $60.3M | 4,843,861 |
| BROWN ADVISORY INC | $56.4M | 4,533,515 |
| AMERICAN CENTURY COMPANIES INC | $43.3M | 3,474,853 |
| GEODE CAPITAL MANAGEMENT, LLC | $39.2M | 3,149,827 |
Companies Similar to ECVT
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
COLLEGIUM PHARMACEUTICAL, INC
Enovis CORP
InnovAge Holding Corp.
PTC THERAPEUTICS, INC.
Travere Therapeutics, Inc.
Alphatec Holdings, Inc.
Envista Holdings Corp
Starling Oncology, Inc.
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put ECVT on your watchlist
Track score changes the day Ecovyst Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is ECVT a good stock to buy?
13F Pro's AI-powered analysis of Ecovyst Inc. (ECVT) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ECVT are available on the ECVT stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ECVT is classified as a small company.
Which hedge funds own ECVT?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ECVT. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Ecovyst Inc.'s investment landscape.